So the negative effect of RPS6KB1 in pancreatic ductal adenocarcinoma and kidney cancer might not weaken the crucial role of RPS6KB1 in NSCLC. The gene discussed is RPS6KB1; the disease is pancreatic ductal adenocarcinoma.